4-Methylphthalazine-1-thione | 54145-23-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 4-Methylphthalazine-1-thione
• 英文别名: 4-methyl-2H-phthalazine-1-thione；4-Methylphthalazine-1-thiol；4-methyl-2H-phthalazine-1-thione
• CAS: 54145-23-2
• 化学式: C₉H₈N₂S
• 分子量: 176.242
• InChiKey: ISYQFYCGFOIYRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  56.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-Methylphthalazine-1-thione 在 盐酸 、 sodium ethanolate 作用下， 以 乙醇 为溶剂， 反应 2.0h， 生成 4-甲基酞嗪-1(2H)-酮
  参考文献：
  名称：

  Badr, M. Z. A.; El-Sherief, H. A.; El-Naggar, G. M., Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 471 - 475

  摘要：

  DOI：
• 作为产物：
  描述：

  4-甲基酞嗪-1(2H)-酮 在 劳森试剂 作用下， 以 甲苯 为溶剂， 生成 4-Methylphthalazine-1-thione
  参考文献：
  名称：

  [EN] COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS
  [FR] COMPOSÉS ET LEUR UTILISATION COMME INHIBITEURS D'HDAC6

  摘要：

  The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, wherein Y1is a 9- or 10-membered bicyclic heteroaryl, Y2is a 5-membered heteroaryl, Z1is selected from (C=O)-R9, S(O)-R9and S(O2)-R9, L is an alkyl-, cycloalkyl- or heterocycloalkyl-based linker, and R1and R9may be various groups. The present invention further relates to a compound of formula (I) as HDAC6 inhibitor, typically for use in the treatment and/or the prevention of an HDAC6-associated disease, such as cancers, neurodegenerative diseases, neuropathies or cardiovascular diseases.

  公开号：

  WO2023118507A2

文献信息

• Photochemistry of conjugated nitrogen-thiocarbonyl systems. VII. Photoaddition of quinoline-, isoquinoline- and phthalazine-thione systems to olefins.
  作者：Eisuke SATO、Yoshiya IKEDA、Yuichi KANAOKA

  DOI：10.1248/cpb.38.1205

  日期：——

  Photolyses of quinoline-2-thiones (1A, B), isoquinoline-1-thione (14A), and phthalazine-1-thiones (14B-D) in the presence of olefins (2) afforded photoaddition products such as substituted quinolines, isoquinolines, phthalazines, and novel tricyclic products, probably by way of thietanes formed by photoaddition of olefins to the C=S bond.

  喹啉-2-硫酮（1A、B）、异喹啉-1-硫酮（14A）以及酞嗪硫酮（14B-D）在烯烃（2）存在下的光解反应，通过烯烃对C=S键的光加成可能形成的硫杂环丁烷途径，提供了取代的喹啉、异喹啉、酞嗪及新型三环产物。
• SATO, EISUKE;IKEDA, YOSHIYA;KANAOKA, YUICHI, CHEM. AND PHARM. BULL., 38,(1990) N, C. 1205-1210
  作者：SATO, EISUKE、IKEDA, YOSHIYA、KANAOKA, YUICHI

  DOI：——

  日期：——
• BADR, M. Z. A.;EL-SHERIEF, H. A.;EL-NAGGAR, G. M.;MAHGOUB, S. A., J. HETEROCYCL. CHEM., 1984, 21, N 2, 471-475
  作者：BADR, M. Z. A.、EL-SHERIEF, H. A.、EL-NAGGAR, G. M.、MAHGOUB, S. A.

  DOI：——

  日期：——
• JAHINE H.; ZAHER H. A.; AKHNOOKH Y.; EL-GENDY Z., INDIAN J. CHEM., 1978, B 16, NO 8, 689-692
  作者：JAHINE H.、 ZAHER H. A.、 AKHNOOKH Y.、 EL-GENDY Z.

  DOI：——

  日期：——
• [EN] COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS<br/>[FR] COMPOSÉS ET LEUR UTILISATION COMME INHIBITEURS D'HDAC6
  申请人：[en]AUGUSTINE THERAPEUTICS

  公开号：WO2023118507A2

  公开（公告）日：2023-06-29

  The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, wherein Y1is a 9- or 10-membered bicyclic heteroaryl, Y2is a 5-membered heteroaryl, Z1is selected from (C=O)-R9, S(O)-R9and S(O2)-R9, L is an alkyl-, cycloalkyl- or heterocycloalkyl-based linker, and R1and R9may be various groups. The present invention further relates to a compound of formula (I) as HDAC6 inhibitor, typically for use in the treatment and/or the prevention of an HDAC6-associated disease, such as cancers, neurodegenerative diseases, neuropathies or cardiovascular diseases.

表征谱图